Meta-Analysis
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3649-3663
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3649
Table 1 Clinical information and characteristics of included studies
Author (year)CountryControlImmuno-therapy interven-tionsPatients
Child-Pugh score A/B/C
Immune cell regimensCourse
ControlTrialControlTrial
Nakamoto (2007)[19]JapanTACETACE + DC11104/7/08/2/05 × 1061
Nakamoto (2011)[20]JapanTACETACE + DC2213NR5/8/05 × 1061
El Ansary (2013)[21]EgyptSupportive treatmentDC15150/14/10/15/020 × 1061
Sun (2015)[22]ChinaResection + FOLFOX6Resection + DC8080NRNR8.9 × 1096
Lee (2017)[23]South KoreaResection/RFA/PEIResection/RFA/PEI + DC7569NRNR3 × 1076
Weng (2007)[24]ChinaTACE + RFATACE + RFA + CIK404533/7/036/9/01.0-1.5 × 10108/9
Dong (2008)[25]ChinaResectionResection + CIK438434/9/068/16/01.0-2.0 × 10103/5
Hao (2010)[26]ChinaTACETACE + RFA + CIK747266/8/065/7/01.0-5.0 × 10104
Pan (2010)[27]ChinaTACE + RFATACE + RFA + CIK3942NRNR1.0 × 10104
Pan (2013)[28]ChinaResectionResection + CIK206204206/0/0204/0/01.0-1.5 × 10104
Lee (2015)[29]South KoreaResection/RFA/PEIResection/RFA/PEI + CIK112114112/0/0114/0/0NR16
Pan (2015)[30]ChinaResectionResection + CIK520511NRNR1.0-1.5 × 10104
Chen (2016)[31]ChinaResectionResection + CIK118231205/12/0222/9/01.0-1.5 × 10104
Li (2016)[32]ChinaOxaliplatin + CapecitabineCIK373733(A + B)/4(C)27(A + B)/10(C)NRNR
Chang (2018)[33]ChinaResectionResection + CIK145145145/0/0145/0/0NRNR
Lee (2018)[34]South KoreaResection/RFA/PEIResection/RFA/PEI + CIK112114112/0/0114/0/06.4 × 10916
Cui (2014)[35]ChinaRFARFA + NK/γδT/CIK323014/18/018/12/01.2-2.0 × 1098
Qian (2016)[36]ChinaRFARFA + NK/γδT/CIK3173NRNR1.0-2.0 × 1098
Qiu (2011)[37]ChinaResectionResection + DC/CIK99NRNR2.0-20.0 × 109NR
Niu (2013)[38]ChinaCryoablationCytotherapy + DC/CIK1221NRNR6.0-10.0 × 109NR
Shimizu (2014)[39]JapanResectionResection + DC/CIK403544/8/034/8/0NRNR
Yu (2015)[40]ChinaMicrowave ablationMicrowave ablation + DC/CIK151415/0/013/1/0NRNR